Section 232 Pharma, Polysilicon Waiver and Foreign IOR Form Updates

Key Points

• Commerce has opened 60 days of public comment on the OMB-approved emergency information collection tied to the Section 232 temporary final rule on specialty pharmaceuticals and associated ingredients (September 23, 2026).
• A second Commerce notice opens 60 days of comment on the application process to waive the import qualification criteria in the polysilicon and polysilicon derivatives anti-stockpiling temporary final rule (September 24, 2026), issued under Proclamation 11052.
• CBP's CSMS # 70381183 announces updates to CBP Form 3461, CBP Form 7501, and their electronic equivalents under an interim final rule on heightened requirements for foreign importers of record.
• The CBP changes come with corresponding responsibilities for licensed customs brokers, under Executive Order 14411, "Strengthening Customs Enforcement," Section 2.

On this page

1. What changed
2. Section 232 specialty pharmaceuticals: information collection
3. Polysilicon anti-stockpiling: waiver application process
4. Foreign importers of record: CBP Form 3461 and 7501 updates
5. What importers should do
6. Key references

The links in this article go to the primary documents: the Federal Register notices and the CBP message themselves. Read the source.

What do these notices mean for importers? Two Commerce notices put the paperwork behind new Section 232 pharmaceutical measures and the polysilicon anti-stockpiling rule out for public comment, and CBP has told filers that entry forms are changing for foreign importers of record. Importers and brokers handling those goods or foreign-IOR entries should review the documents now.

What changed

Three items landed within a day of each other. Two are Paperwork Reduction Act notices from the Department of Commerce, published in the Federal Register on November 6, 2026. The third is a CBP Cargo Systems Messaging Service message dated November 6, 2026. The Commerce notices do not themselves set duty rates. They concern the information that importers must provide under temporary final rules already issued.

Section 232 specialty pharmaceuticals: information collection

Commerce's notice covers the information collection for the temporary final rule "Section 232 National Security Adjustments to Imports of Specialty Pharmaceuticals and Associated Ingredients," dated September 23, 2026. OMB has approved the collection on an emergency basis. The notice allows 60 days of public comment on it.

The notice is aimed at assessing the impact of the information requirements and minimizing reporting burden. If you import specialty pharmaceuticals or their ingredients, the comment period is your chance to tell Commerce what the collection costs you in practice. The scope of covered products and any rate details sit in the underlying temporary final rule, so read that rule rather than relying on this notice.

Polysilicon anti-stockpiling: waiver application process

A separate Commerce notice covers the "Application Process To Waive the Import Qualification Criteria" under the temporary final rule "Measures To Restrict Stockpiling of Polysilicon and Polysilicon Derivatives Under Proclamation 11052," dated September 24, 2026. As with the pharmaceutical notice, OMB approved the emergency collection and Commerce is allowing 60 days of public comment.

The title tells you the structure: the rule sets import qualification criteria to restrict stockpiling, and there is an application process to seek a waiver of those criteria. Importers of polysilicon and derivatives who may need a waiver should review what the application collects and comment if the burden is unreasonable.

Foreign importers of record: CBP Form 3461 and 7501 updates

CBP's CSMS # 70381183 says CBP is updating CBP Form 3461 (entry/immediate delivery), CBP Form 7501 (entry summary), and their electronic equivalents. The updates follow an interim final rule on heightened requirements for foreign importers of record. CBP cites Executive Order 14411, "Strengthening Customs Enforcement," Section 2, and governing statutes as its authority.

CBP states that it is establishing new requirements for foreign IORs when making entry, along with corresponding responsibilities for licensed customs brokers. The summary available here does not give the specific data elements, effective dates, or ACE changes, so check the full CSMS message and the interim final rule for those details before changing your filing process.

What importers should do

• Pull the Section 232 specialty pharmaceutical and polysilicon temporary final rules, and decide whether to file comments within the 60-day windows.
• If you may need a polysilicon waiver, review the application requirements in the Commerce notice and identify who will collect the required information.
• If you file entries for foreign importers of record, or act as the broker, read CSMS # 70381183 and the interim final rule, then confirm with your software provider how Forms 3461 and 7501 will change.
• Review your broker-client agreements for the new broker responsibilities CBP describes for foreign-IOR entries.

Key references

• Commerce PRA notice: Section 232 specialty pharmaceuticals and associated ingredients: 60-day comment request on the emergency information collection.
• Commerce PRA notice: polysilicon waiver application process: 60-day comment request on the waiver application under Proclamation 11052 measures.
• CBP CSMS # 70381183: updates to Forms 3461 and 7501 for foreign importers of record.
• Federal Register: landing page for the temporary final rules and interim final rule referenced above.